Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 62 items for :

  • "growth hormone treatment" x
Clear All
Juliane Léger Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Service d’Endocrinologie Diabétologie Pédiatrique, Centre de Référence des Maladies Endocriniennes de la Croissance et du développement, Paris, France
Université Paris Diderot, Sorbonne Paris Cité, Paris, France
Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 1141, DHU PROTECT, Paris, France

Search for other papers by Juliane Léger in
Google Scholar
PubMed Close
,
Anne Fjellestad-Paulsen Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Service d’Endocrinologie Diabétologie Pédiatrique, Centre de Référence des Maladies Endocriniennes de la Croissance et du développement, Paris, France

Search for other papers by Anne Fjellestad-Paulsen in
Google Scholar
PubMed Close
,
Anne Bargiacchi Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Service de Psychiatrie de l’Enfant et de l’Adolescent, Centre de Référence des Maladies Endocriniennes de la Croissance et du développement, Paris, France

Search for other papers by Anne Bargiacchi in
Google Scholar
PubMed Close
,
Catherine Doyen Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Service de Psychiatrie de l’Enfant et de l’Adolescent, Centre de Référence des Maladies Endocriniennes de la Croissance et du développement, Paris, France

Search for other papers by Catherine Doyen in
Google Scholar
PubMed Close
,
Emmanuel Ecosse Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Service d’Endocrinologie Diabétologie Pédiatrique, Centre de Référence des Maladies Endocriniennes de la Croissance et du développement, Paris, France

Search for other papers by Emmanuel Ecosse in
Google Scholar
PubMed Close
,
Jean-Claude Carel Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Service d’Endocrinologie Diabétologie Pédiatrique, Centre de Référence des Maladies Endocriniennes de la Croissance et du développement, Paris, France
Université Paris Diderot, Sorbonne Paris Cité, Paris, France
Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 1141, DHU PROTECT, Paris, France

Search for other papers by Jean-Claude Carel in
Google Scholar
PubMed Close
, and
Marie-France Le Heuzey Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Service de Psychiatrie de l’Enfant et de l’Adolescent, Centre de Référence des Maladies Endocriniennes de la Croissance et du développement, Paris, France

Search for other papers by Marie-France Le Heuzey in
Google Scholar
PubMed Close

-controlled study . Journal of Clinical Endocrinology and Metabolism 2010 95 4889 – 4897 . ( doi:10.1210/jc.2010-0493 ) 10.1210/jc.2010-0493 22 Leger J Garel C Fjellestad-Paulsen A Hassan M Czernichow P. Human growth hormone treatment

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0200
Volume/Issue:
Volume 6: Issue 8
Open access
Alicia Romano Department of Pediatrics, New York Medical College, Valhalla, New York, USA

Search for other papers by Alicia Romano in
Google Scholar
PubMed Close
,
Juan Pablo Kaski Centre for Inherited Cardiovascular Diseases, Great Ormond Street Hospital & UCL Institute of Cardiovascular Science, London, UK

Search for other papers by Juan Pablo Kaski in
Google Scholar
PubMed Close
,
Jovanna Dahlgren Department of Paediatrics, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Jovanna Dahlgren in
Google Scholar
PubMed Close
,
Nicky Kelepouris US Medical Affairs, Novo Nordisk Inc., Plainsboro, New Jersey, USA

Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed Close
,
Alberto Pietropoli Global Medical Affairs, Novo Nordisk Health Care AG, Zurich, Switzerland

Search for other papers by Alberto Pietropoli in
Google Scholar
PubMed Close
,
Tilman R Rohrer Department of Pediatric Endocrinology, University Children’s Hospital, Saarland University Medical Center, Homburg, Germany

Search for other papers by Tilman R Rohrer in
Google Scholar
PubMed Close
, and
Michel Polak Paediatric Endocrinology, Diabetology and Gynaecology Department, Hôpital Universitaire Necker Enfants-Malades, AP-HP, Université de Paris, Imagine Institute, Paris, France

Search for other papers by Michel Polak in
Google Scholar
PubMed Close

– GHT, growth hormone treatment. Five cardiovascular comorbidities in five patients were reported after the initiation of GH treatment: three cases of unspecified cardiovascular disease, one case of PVS and one ruptured abdominal aortic

Article Type:
Research Article
Collections:
Cardiovascular
DOI:
https://doi.org/10.1530/EC-21-0549
Volume/Issue:
Volume 11: Issue 1
Open access
Ping Li Department of Endocrinology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China

Search for other papers by Ping Li in
Google Scholar
PubMed Close
,
Fei Cheng Department of Endocrinology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China

Search for other papers by Fei Cheng in
Google Scholar
PubMed Close
, and
Lei Xiu Department of Endocrinology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China

Search for other papers by Lei Xiu in
Google Scholar
PubMed Close

Hoorweg-Nijman JJ Vulsma T Stokvis-Brantsma WH Rouwé CW , Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens . Journal of Clinical Endocrinology and Metabolism 2003 88 1119

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0115
Volume/Issue:
Volume 7: Issue 4
Open access
Alessandro Ciresi Section of Endocrinology, Biomedical Department of Internal and Specialist Medicine (DIBIMIS), University of Palermo, Palermo, Italy

Search for other papers by Alessandro Ciresi in
Google Scholar
PubMed Close
,
Stefano Radellini Section of Endocrinology, Biomedical Department of Internal and Specialist Medicine (DIBIMIS), University of Palermo, Palermo, Italy

Search for other papers by Stefano Radellini in
Google Scholar
PubMed Close
,
Valentina Guarnotta Section of Endocrinology, Biomedical Department of Internal and Specialist Medicine (DIBIMIS), University of Palermo, Palermo, Italy

Search for other papers by Valentina Guarnotta in
Google Scholar
PubMed Close
,
Maria Grazia Mineo Section of Endocrinology, Biomedical Department of Internal and Specialist Medicine (DIBIMIS), University of Palermo, Palermo, Italy

Search for other papers by Maria Grazia Mineo in
Google Scholar
PubMed Close
, and
Carla Giordano Section of Endocrinology, Biomedical Department of Internal and Specialist Medicine (DIBIMIS), University of Palermo, Palermo, Italy

Search for other papers by Carla Giordano in
Google Scholar
PubMed Close

P Pedersen BT Rakov V Ross J . Gender influences short-term growth hormone treatment response in children . Hormone Research in Paediatrics 2012 77 188 – 194 . ( https://doi.org/10.1159/000337570 ) 22508317 10.1159/000337570 32

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0135
Volume/Issue:
Volume 7: Issue 7
Open access
Sherwin Criseno Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
School of Nursing and Midwifery, Institute of Clinical Sciences, University of Birmingham, UK

Search for other papers by Sherwin Criseno in
Google Scholar
PubMed Close
,
Helena Gleeson Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Helena Gleeson in
Google Scholar
PubMed Close
,
Andrew A Toogood Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Andrew A Toogood in
Google Scholar
PubMed Close
,
Neil Gittoes Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Neil Gittoes in
Google Scholar
PubMed Close
,
Anne Topping School of Nursing and Midwifery, Institute of Clinical Sciences, University of Birmingham, UK

Search for other papers by Anne Topping in
Google Scholar
PubMed Close
, and
Niki Karavitaki Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Niki Karavitaki in
Google Scholar
PubMed Close

years and over) with growth hormone deficiency (GHD) on growth hormone (GH) treatment (responses to question 3: ‘How many of your adult patients on growth hormone treatment are over the age of 25 years?’). Figure 3 Number of adult patients

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-23-0533
Volume/Issue:
Volume 13: Issue 5
Open access
Charlotte Höybye Patient Area Endocrinology and Nephrology, Infection and Inflammation Theme, Karolinska University Hospital, Stockholm, Sweden
Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden

Search for other papers by Charlotte Höybye in
Google Scholar
PubMed Close
,
Laia Faseh Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden

Search for other papers by Laia Faseh in
Google Scholar
PubMed Close
,
Christos Himonakos Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden
Department of Medicine, Karlstad Hospital, Karlstad, Sweden

Search for other papers by Christos Himonakos in
Google Scholar
PubMed Close
,
Tomasz Pielak NUTOPI Sp. z o. o., Poznan, Poland

Search for other papers by Tomasz Pielak in
Google Scholar
PubMed Close
, and
Jesper Eugen-Olsen Clinical Research Centre, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark

Search for other papers by Jesper Eugen-Olsen in
Google Scholar
PubMed Close

Growth hormone deficiency (GHD) syndrome is associated with adverse levels of several risk factors for cardiovascular diseases (CVD), including metabolic inflammation. However, the impact of GHD and GH treatment on low-grade inflammation is unknown. The aim of the study was to establish the level of the low-grade inflammation biomarker soluble urokinase plasminogen activator receptor (suPAR) in adults with GHD and the response to long-term GH treatment. Measurements of suPAR and CRP were performed in bio-bank serum samples from 72 adults, 34 males and 38 females, with GHD before and during at least 5 years of GH treatment. Mean age was 52.5 ± 15.5 years, BMI 27.3 ± 5 kg/m2. Clinical evaluations and blood sampling were performed at routine visits. Data on demography, anthropometry, lab results and clinical events were retrieved from post-marketing surveillance study databases and medical records. suPAR and high-sensitive (hs) CRP were analysed using ELISA and immunochemistry, respectively. At baseline blood pressure, lipid profile and fasting glucose were within the normal reference range. Baseline geometric mean and 95% CI of suPAR was 2.9 (2.7–3.3) ng/mL and of CRP 2.3 (0.6–4.0) mg/L. Mean follow-up was 8 ± 2 years. The suPAR levels remained stable during follow-up, although individual increases were seen on occurrence or presence of co-morbidities. In contrast, levels of CRP decreased. In conclusion, the decrease in CRP and indirectly the absence of an expected increase in suPAR over time indicates a favourable effect of GH on low-grade inflammation.

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0159
Volume/Issue:
Volume 8: Issue 6
Open access
Martin Bidlingmaier Medizinische Klinik und Poliklinik IV, LMU Klinikum, Ludwig-Maximilians University, Munich, Germany

Search for other papers by Martin Bidlingmaier in
Google Scholar
PubMed Close
,
Helena Gleeson Department of Endocrinology, Queen Elizabeth Hospital, Birmingham, UK

Search for other papers by Helena Gleeson in
Google Scholar
PubMed Close
,
Ana-Claudia Latronico Department of Internal Medicine, Discipline of Endocrinology and Metabolism, Sao Paulo Medical School, University of Sao Paulo, Sao Paulo, Brazil

Search for other papers by Ana-Claudia Latronico in
Google Scholar
PubMed Close
, and
Martin O Savage Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, London, UK

Search for other papers by Martin O Savage in
Google Scholar
PubMed Close

Growth Response Study Group . A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency . European Journal of Endocrinology 2001 144 13 – 20 . ( https://doi.org/10.1530/eje.0

Article Type:
Review Article
Collections:
Paediatric Endocrinology
DOI:
https://doi.org/10.1530/EC-22-0177
Volume/Issue:
Volume 11: Issue 10
Open access
Urszula Smyczyńska Department of Automatics and Biomedical Engineering, AGH University of Science and Technology, Krakow, Poland

Search for other papers by Urszula Smyczyńska in
Google Scholar
PubMed Close
,
Joanna Smyczyńska Department of Endocrinology and Metabolic Diseases, Polish Mother’s Memorial Hospital – Research Institute, Lodz, Poland

Search for other papers by Joanna Smyczyńska in
Google Scholar
PubMed Close
,
Maciej Hilczer Department of Endocrinology and Metabolic Diseases, Polish Mother’s Memorial Hospital – Research Institute, Lodz, Poland
Department of Paediatric Endocrinology, Medical University of Lodz, Lodz, Poland

Search for other papers by Maciej Hilczer in
Google Scholar
PubMed Close
,
Renata Stawerska Department of Endocrinology and Metabolic Diseases, Polish Mother’s Memorial Hospital – Research Institute, Lodz, Poland

Search for other papers by Renata Stawerska in
Google Scholar
PubMed Close
,
Ryszard Tadeusiewicz Department of Automatics and Biomedical Engineering, AGH University of Science and Technology, Krakow, Poland

Search for other papers by Ryszard Tadeusiewicz in
Google Scholar
PubMed Close
, and
Andrzej Lewiński Department of Endocrinology and Metabolic Diseases, Polish Mother’s Memorial Hospital – Research Institute, Lodz, Poland
Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Lodz, Poland

Search for other papers by Andrzej Lewiński in
Google Scholar
PubMed Close

paediatric endocrinology workshop . Journal of Clinical Endocrinology and Metabolism 2008 93 4210 – 4217 . ( https://doi.org/10.1210/jc.2008-0509 ) 10.1210/jc.2008-0509 3 Ranke MB . New paradigms for growth hormone treatment in the 21st century

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0277
Volume/Issue:
Volume 7: Issue 1
Open access
Christine Poitou Assistance Publique-Hôpitaux de Paris, Centre de référence Maladies Rares (PRADORT, Syndrome de Prader-Willi et autres formes rares d’obésité avec troubles du comportement alimentaire), Service de Nutrition, Hôpital Pitié-Salpêtrière, Paris, France

Search for other papers by Christine Poitou in
Google Scholar
PubMed Close
,
Anthony Holland Department of Psychiatry, University of Cambridge, UK

Search for other papers by Anthony Holland in
Google Scholar
PubMed Close
,
Charlotte Höybye Department of Endocrinology and Department of Molecular Medicine and Surgery, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden

Search for other papers by Charlotte Höybye in
Google Scholar
PubMed Close
,
Laura C G de Graaff Center for Adults with Rare Genetic Syndromes, Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands

Search for other papers by Laura C G de Graaff in
Google Scholar
PubMed Close
,
Sandrine Bottius Assistance Publique-Hôpitaux de Paris, Centre de référence Maladies Rares (PRADORT, Syndrome de Prader-Willi et autres formes rares d’obésité avec troubles du comportement alimentaire), Service de Nutrition, Hôpital Pitié-Salpêtrière, Paris, France

Search for other papers by Sandrine Bottius in
Google Scholar
PubMed Close
,
Berit Otterlei Landsforeningen for Prader-Willis Syndrom Hiltonåsen, Slependen, Norway

Search for other papers by Berit Otterlei in
Google Scholar
PubMed Close
, and
Maithé Tauber Centre de référence Maladies Rares (PRADORT, Syndrome de Prader-Willi et autres formes rares d’obésité avec troubles du comportement alimentaire), Service d’Endocrinologie, Obésités, Maladies Osseuses, Génétique et Gynécologie Médicale, Hôpital des Enfants, Toulouse, France

Search for other papers by Maithé Tauber in
Google Scholar
PubMed Close

endocrinologist's point of view Growth hormone treatment GH treatment is for more than three decades a well-established and approved treatment in children with PWS in many countries ( 2 , 16 , 17 ). In contrast, PWS is an approved indication for GH

Article Type:
Review Article
Collections:
Paediatric Endocrinology
DOI:
https://doi.org/10.1530/EC-22-0373
Volume/Issue:
Volume 12: Issue 1
Open access
M Guftar Shaikh Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, UK
Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK

Search for other papers by M Guftar Shaikh in
Google Scholar
PubMed Close
,
Timothy G Barrett Department of Endocrinology, Birmingham Womens and Children’s Hospital, Birmingham, UK
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

Search for other papers by Timothy G Barrett in
Google Scholar
PubMed Close
,
Nicola Bridges Department of Paediatric Endocrinology, Chelsea and Westminster Hospital, London, UK

Search for other papers by Nicola Bridges in
Google Scholar
PubMed Close
,
Robin Chung Research Working Group, Prader-Willi Syndrome Association, Northampton, UK

Search for other papers by Robin Chung in
Google Scholar
PubMed Close
,
Evelien F Gevers Department of Paediatric Endocrinology, Barts Health NHS Trust, Royal London Hospital, London, UK
Centre for Endocrinology, William Harvey Research Institute, Barts and The London Medical School, Queen Mary University of London, London, UK

Search for other papers by Evelien F Gevers in
Google Scholar
PubMed Close
,
Anthony P Goldstone PsychoNeuroEndocrinologyResearch Group, Division of Psychiatry, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK

Search for other papers by Anthony P Goldstone in
Google Scholar
PubMed Close
,
Anthony Holland Department of Psychiatry, University of Cambridge, Cambridge, UK

Search for other papers by Anthony Holland in
Google Scholar
PubMed Close
,
Shankar Kanumakala Royal Alexandra Children’s Hospital, Brighton, UK

Search for other papers by Shankar Kanumakala in
Google Scholar
PubMed Close
,
Ruth Krone Department of Endocrinology, Birmingham Womens and Children’s Hospital, Birmingham, UK

Search for other papers by Ruth Krone in
Google Scholar
PubMed Close
,
Andreas Kyriakou Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, UK
Department of Paediatric Endocrinology, Makarios Children's Hospital, Nicosia, Cyprus

Search for other papers by Andreas Kyriakou in
Google Scholar
PubMed Close
,
E Anne Livesey Royal Alexandra Children’s Hospital, Brighton, UK
Sussex Community NHS Trust, Brighton, UK

Search for other papers by E Anne Livesey in
Google Scholar
PubMed Close
,
Angela K Lucas-Herald Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, UK
Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK

Search for other papers by Angela K Lucas-Herald in
Google Scholar
PubMed Close
,
Christina Meade CHI at Tallaght University Hospital, Dublin, Republic of Ireland

Search for other papers by Christina Meade in
Google Scholar
PubMed Close
,
Susan Passmore Prader-Willi Syndrome Association, Northampton, UK

Search for other papers by Susan Passmore in
Google Scholar
PubMed Close
,
Edna Roche CHI at Tallaght University Hospital, Dublin, Republic of Ireland
The University of Dublin, Trinity College Dublin, Dublin, Republic of Ireland

Search for other papers by Edna Roche in
Google Scholar
PubMed Close
,
Chris Smith Royal Alexandra Children’s Hospital, Brighton, UK

Search for other papers by Chris Smith in
Google Scholar
PubMed Close
, and
Sarita Soni Learning Disability Psychiatry, NHS Greater Glasgow and Clyde, Glasgow, UK

Search for other papers by Sarita Soni in
Google Scholar
PubMed Close

. TA64. London, UK: NICE , 2003 . (available at: https://www.nice.org.uk/guidance/ta64 ) 61 Passone CGB Franco RR Ito SS Trindade E Polak M Damiani D & Bernardo WM . Growth hormone treatment in Prader-Willi syndrome patients

Article Type:
Other
Collections:
Obesity
DOI:
https://doi.org/10.1530/EC-24-0091
Volume/Issue:
Volume 13: Issue 8
Open access